Polyrizon Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

6.46M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

PLRZ News

21 days ago - Polyrizon Announces Publication of U.S. National Patent Application for Its Innovative Hydrogel Nasal Technologies - GlobeNewsWire
4 weeks ago - Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs - GlobeNewsWire
4 weeks ago - Polyrizon's Moving Forward with Expected 2025 Clinical Trial - Entered Manufacturing Agreement for its PL-14 Allergy Blocker - GlobeNewsWire
5 weeks ago - Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance - GlobeNewsWire
7 weeks ago - Polyrizon Enters into GMP Manufacturing Agreement for CTM Supply of its PL-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial - GlobeNewsWire
2 months ago - Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ) - Accesswire
2 months ago - Polyrizon Announces Closing of $4.2 Million Initial Public Offering - GlobeNewsWire
3 months ago - Polyrizon Announces Pricing of $4.2 Million Initial Public Offering and Listing on the Nasdaq Capital Market Under New Ticker “PLRZ” - GlobeNewsWire

More News